Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada.
暂无分享,去创建一个
B. Andresen | P. Waters | G. Horvath | H. Vallance | S. Stockler-Ipsiroglu | A. Davidson | J. Palaty | J. Nelson | S. Olpin | Y. Lillquist
[1] H. Waterham,et al. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. , 2006, The Journal of pediatrics.
[2] Bernhard Liebl,et al. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium‐chain acyl‐CoA dehydrogenase deficiency , 2005, Human mutation.
[3] B. Wilcken,et al. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency , 2002, The Lancet.
[4] D. Marsden,et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. , 2001, Clinical chemistry.
[5] B. Wilcken,et al. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies , 2001, Archives of disease in childhood. Fetal and neonatal edition.
[6] I Knudsen,et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. , 2001, American journal of human genetics.
[7] D. Rabier,et al. Recognition and management of fatty acid oxidation defects: A series of 107 patients , 1999, Journal of Inherited Metabolic Disease.
[8] D. Chace,et al. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. , 1997, Clinical chemistry.
[9] S. Packman,et al. The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? , 1997, Human molecular genetics.
[10] Y. T. Chen,et al. Disease-causing mutations in exon 11 of the medium-chain acyl-CoA dehydrogenase gene. , 1994, American journal of human genetics.
[11] C. Roe,et al. Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. , 1994, The Journal of pediatrics.
[12] Y. T. Chen,et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. , 1993, American journal of human genetics.
[13] N. Manning,et al. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts , 1990, Journal of Inherited Metabolic Disease.
[14] P. Ozand. Medium chain acyl CoA dehydrogenase deficiency , 2005 .
[15] K. Tanaka,et al. Mutations in the medium chain acyl‐CoA dehydrogenase (MCAD) gene , 1992, Human mutation.